Clinically, there are two predominant issues associated with the treatment of infections in hospitals.

  • Firstly, failure of treatment of serious infections is still associated with high rates of morbidity and mortality.
  • Secondly, resistance to antimicrobials continues to escalate and the number of patients with untreatable infections due to resistance is becoming more common. 

Research to address these issues is of major significance to the global healthcare community. 

We have identified several critical research objectives to confront the critical and worsening problem of antimicrobial resistance in special patient populations. Under each of these objectives, a series of projects will be undertaken to enable, for the first time, the development and testing of novel evidence-based dosing regimens to prolong the lives of our current antimicrobials.

Click on the objectives at the top of the page for more information about each of the objectives, and the component projects.